|
Office Locations:
|
101 South Hanley Road Suite 200
Clayton, MO 63105
Phone: 314-733-8100
Fax: 314-733-8678
| | |
|
|
|
Information Technology
Life Sciences & Healthcare
Medical Device
|
|
|
Established within Ascension Health in 2001, AHV is a strategic healthcare venture fund focused on the medical device, technology and service sectors. Ascension Health is the nation's largest Catholic and largest nonprofit health system serving patients through a network of hospitals and health facilities in 20 states and the District of Columbia. The fund has a commitment to invest in expansion to late-stage healthcare companies. The firm invests approximately $10 million per round and up to $15 million per company. In 2007, AHV closed a second fund, CHV II, LP with $200 million in commitments from Ascension Health, Catholic Health Initiatives and Catholic Health East. CHV II will continue the investment strategy that AHV employed in its first fund, targeting expansion to later stage medical device, healthcare technology, and healthcare service companies in areas of interest to the limited partners. A portion of the fund will also be committed to other healthcare venture funds. finalized its latest strategic venture capital fund at $255 million. The firm announced its fourth fund CHV IV, L.P. in December of 2016, which brings the firm's total assets under management to more than $1 billion. CHV IV fund was backed by 13 health system partners.
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|